Darius Mehregan, MD
Dermatopathology · Monroe, MINPI 1497738454
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,600 of the $3,958 with a category attached, or 65.7%. UCB, Inc. accounts for 66.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $2,965 and has fallen 84.3% since, to $464 in 2025.
Across 38 payments — averaging $104.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$3K
- AbbVie$322
- Sun Pharmaceutical Industries Inc.$167
- Regeneron Healthcare Solutions, Inc.$159
- Galderma Laboratories, L.p.$159
- Mallinckrodt Enterprises LLC$99
- plus $428 from 11 others
What the payments were for
- Consulting fees$2,60066%
- Food & beverage$1,35834%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 2 | $2,623 |
| AbbVie | 11 | $322 |
| Sun Pharmaceutical Industries Inc. | 3 | $167 |
| Regeneron Healthcare Solutions, Inc. | 4 | $159 |
| Galderma Laboratories, L.p. | 2 | $159 |
| Mallinckrodt Enterprises LLC | 1 | $99 |
| Lilly USA, LLC | 1 | $85 |
| Cashflow Solutions, LLC | 2 | $58 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $56 |
| Boehringer Ingelheim | 2 | $56 |
| Johnson & Johnson | 1 | $33 |
| Smith+Nephew | 1 | $33 |
| Janssen Scientific Affairs, LLC | 1 | $27 |
| Biofrontera Inc. | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Omeza LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,958 in reported general payments places this provider in the 80th percentile of 28 dermatopathology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 33 | $791 |
| Triamcinolone Acetonide | 51 | $384 |
| Clobetasol Propionate | 11 | $235 |
| Hydrocortisone | 23 | $223 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Monroe
- Corinne RauckMonroe$352
- Viktor GoncharukMonroe$78
- David StockmanSaginaw$24K
- Marek StawiskiGrand Rapids$23K
- Juan VasquezGrandville$13K
- Brandon McNallyGrandville$8K
- Nicole BossenbroekNorton Shores$6K
- John PelachykColumbus$3K
- Fred NoviceBloomfield Hills$2K
- Neldagae ChisaBloomfield Hills$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.